Oncology

FDA updates breast implant–associated lymphoma cases, risk

The Food and Drug Administration has received 414 reports of cases of breast implant–associated ...

Accelerated breast irradiation advocated by ASTRO guideline

FROM PRACTICAL RADIATION ONCOLOGY Hypofractionation is the preferred means of giving whole breast irradiation ...

TACE plus radiotherapy improves outcomes in poor-prognosis hepatocellular carcinoma

FROM JAMA ONCOLOGY Use of transarterial chemoembolization (TACE) plus external beam radiotherapy may improve ...

FDA approves new option in Hodgkin lymphoma treatment

The Food and Drug Administration has approved brentuximab vedotin, in combination with chemotherapy, for ...

cSCC staging systems poorly determine metastasis risk

FROM JAMA DERMATOLOGY Current staging systems for cutaneous squamous cell carcinoma (cSCC) poorly discerned ...

Time to rethink MCL treatment, trial design

FROM JAMA ONCOLOGY Classic mantle cell lymphoma (cMCL) has long been treated as a ...